Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

BACKGROUND: Improvement in treatment for patients with recurrent ovarian cancer is needed. Standard therapy in patients with platinum-sensitive recurrent ovarian cancer consists of platinum-based chemotherapy. Median overall survival is reported between 18 and 35 months. Currently, the role of surge...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Laar, Rafli, Zusterzeel, Petra LM, Van Gorp, Toon, Buist, Marrije R, van Driel, Willemien J, Gaarenstroom, Katja N, Arts, Henriette JG, van Huisseling, Johannes CM, Hermans, Ralph HM, Pijnenborg, Johanna MA, Schutter, Eltjo MJ, Pelikan, Harold MP, Vollebergh, Jos HA, Engelen, Mirjam JA, IntHout, Joanna, Kruitwagen, Roy FPM, Massuger, Leon FAG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897943/
https://www.ncbi.nlm.nih.gov/pubmed/24422892
http://dx.doi.org/10.1186/1471-2407-14-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897943/
https://www.ncbi.nlm.nih.gov/pubmed/24422892
http://dx.doi.org/10.1186/1471-2407-14-22

Ejemplares similares